Waldenstrom macroglobulinemia: prognosis and management

por Oza, A, Rajkumar, S V
Publicado 2015

Waldenstrom macroglobulinemia: prognosis and management

por Oza, A, Rajkumar, S V
Publicado 2016

Optimal chemotherapy treatment for women with recurrent ovarian cancer

por Fung-Kee-Fung, M., Oliver, T., Elit, L., Oza, A., Hirte, H.W., Bryson, P.
Publicado 2007

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients

por Wilbaux, M, Hénin, E, Oza, A, Colomban, O, Pujade-Lauraine, E, Freyer, G, Tod, M, You, B
Publicado 2014

2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.

por Hickish, T., Serafinowski, P., Cunningham, D., Oza, A., Dorland, E., Judson, I., Millar, B. C., Lister, T. A., Roldan, A.
Publicado 1993

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.

por Rohatiner, A. Z., Bassan, R., Battista, R., Barnett, M. J., Gregory, W., Lim, J., Amess, J., Oza, A., Barbui, T., Horton, M.
Publicado 1990

Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.

por Oza, A. M., Ganesan, T. S., Dorreen, M., Johnson, P. W., Waxman, J., Gregory, W., Lim, J., Wright, J., Dadiotis, L., Barbounis, V.
Publicado 1992

Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours

por Chen, X, Oza, A M, Kusenda, Z, Yi, Q-L, Kochman, D, Moore, M J, Davis, A J, Siu, L L
Publicado 2003

A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium

por Lheureux, S, Oza, A M, Laurie, S A, Halford, R, Jonker, D, Chen, E, Keller, D, Bourade, V, Wang, L, Doyle, L, Siu, L L, Goel, R
Publicado 2015

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

por Townsley, C A, Major, P, Siu, L L, Dancey, J, Chen, E, Pond, G R, Nicklee, T, Ho, J, Hedley, D, Tsao, M, Moore, M J, Oza, A M
Publicado 2006

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

por Duran, I, Kortmansky, J, Singh, D, Hirte, H, Kocha, W, Goss, G, Le, L, Oza, A, Nicklee, T, Ho, J, Birle, D, Pond, G R, Arboine, D, Dancey, J, Aviel-Ronen, S, Tsao, M-S, Hedley, D, Siu, L L
Publicado 2006

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

por Ledermann, J.A., Embleton-Thirsk, A.C., Perren, T.J., Jayson, G.C., Rustin, G.J.S., Kaye, S.B., Hirte, H., Oza, A., Vaughan, M., Friedlander, M., González-Martín, A., Deane, E., Popoola, B., Farrelly, L., Swart, A.M., Kaplan, R.S., Parmar, M.K.B.
Publicado 2021

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

por Sahebjam, S, Bedard, P L, Castonguay, V, Chen, Z, Reedijk, M, Liu, G, Cohen, B, Zhang, W-J, Clarke, B, Zhang, T, Kamel-Reid, S, Chen, H, Ivy, S P, Razak, A R A, Oza, A M, Chen, E X, Hirte, H W, McGarrity, A, Wang, L, Siu, L L, Hotte, S J
Publicado 2013

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consort...

por Köbel, M, Madore, J, Ramus, S J, Clarke, B A, Pharoah, P D P, Deen, S, Bowtell, D D, Odunsi, K, Menon, U, Morrison, C, Lele, S, Bshara, W, Sucheston, L, Beckmann, M W, Hein, A, Thiel, F C, Hartmann, A, Wachter, D L, Anglesio, M S, Høgdall, E, Jensen, A, Høgdall, C, Kalli, K R, Fridley, B L, Keeney, G L, Fogarty, Z C, Vierkant, R A, Liu, S, Cho, S, Nelson, G, Ghatage, P, Gentry-Maharaj, A, Gayther, S A, Benjamin, E, Widschwendter, M, Intermaggio, M P, Rosen, B, Bernardini, M Q, Mackay, H, Oza, A, Shaw, P, Jimenez-Linan, M, Driver, K E, Alsop, J, Mack, M, Koziak, J M, Steed, H, Ewanowich, C, DeFazio, A, Chenevix-Trench, G, Fereday, S, Gao, B, Johnatty, S E, George, J, Galletta, L, Goode, E L, Kjær, S K, Huntsman, D G, Fasching, P A, Moysich, K B, Brenton, J D, Kelemen, L E
Publicado 2014